Long-Term Efficacy and Safety of Mesenchymal Regenerative Medicine in Decompensated Liver Cirrhosis: A Randomized Controlled Trial
Mesenchymal stem cell (MSC) therapy has gained attention as a potential treatment for decompensated liver cirrhosis (DLC), a severe form of liver disease that occurs when the liver can no longer function properly. Liver cirrhosis, especially when caused by chronic hepatitis B (HBV), leads to a significant decline in health, and current treatments do not…
